| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |